[HTML][HTML] The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
BACKGROUND Despite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
[HTML][HTML] The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H Bolouri, C Speake, D Skibinski, SA Long… - 2020 - europepmc.org
Despite a rapidly growing body of literature on COVID-19, our understanding of the immune
correlates of disease severity, course and outcome remains poor. Using mass cytometry, we …
correlates of disease severity, course and outcome remains poor. Using mass cytometry, we …
[HTML][HTML] The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H Bolouri, C Speake, D Skibinski, SA Long… - The Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Despite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H Bolouri, C Speake, D Skibinski… - Journal of Clinical …, 2021 - search.proquest.com
BACKGROUND. Despite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.
H Bolouri, C Speake, D Skibinski… - Journal of Clinical …, 2021 - search.ebscohost.com
BACKGROUND. Despite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.
H Bolouri, C Speake, D Skibinski, SA Long… - 2021 - cabidigitallibrary.org
BACKGROUND. Despite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.
H Bolouri, C Speake, D Skibinski, SA Long… - Journal of Clinical …, 2021 - go.gale.com
BACKGROUND. Despite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H Bolouri, C Speake, D Skibinski… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
BACKGROUNDDespite a rapidly growing body of literature on coronavirus disease 2019
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
(COVID-19), our understanding of the immune correlates of disease severity, course, and …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H Bolouri, C Speake, D Skibinski, SA Long… - 2020 - pesquisa.bvsalud.org
Despite a rapidly growing body of literature on COVID-19, our understanding of the immune
correlates of disease severity, course and outcome remains poor. Using mass cytometry, we …
correlates of disease severity, course and outcome remains poor. Using mass cytometry, we …
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H Bolouri, C Speake, D Skibinski, SA Long… - bioRxiv, 2020 - biorxiv.org
Despite a rapidly growing body of literature on COVID-19, our understanding of the immune
correlates of disease severity, course and outcome remains poor. Using mass cytometry, we …
correlates of disease severity, course and outcome remains poor. Using mass cytometry, we …